2023 Form 5500 filing — Novartis Corporation Investment Savings Plan
Plain-English filing summary
According to public Form 5500 filings published through the U.S. Department of Labor (DOL) Employee Benefits Security Administration (EBSA) via the EFAST2 system, this is the 2023 Form 5500 filing (EFAST2 acknowledgement 20241007095904NAL0030523218001) for Novartis Corporation Investment Savings Plan, reported by Novartis Corporation under EIN 13-1834433 and plan number 055. It reports 27,459 participants. Attached schedules in the loaded dataset include Schedule H (large plan financials).
- EFAST2 acknowledgement
- 20241007095904NAL0030523218001
- Filing year
- 2023
- Form type
- 2
- Plan sponsor
- Novartis Corporation
- EIN
- 13-1834433
- Plan number
- 055
- Location
- East Hanover, NJ
- Participants
- 27,459
- Schedules available
- Schedule H
- Received date
- not reported in the loaded dataset
Reported financial snapshot (2023)
- Total assets (EOY)
- $9,522,901,746
- Total liabilities (EOY)
- $0
- Net assets (EOY)
- $9,522,901,746
- Employer contributions
- $295,947,937
- Participant contributions
- $274,243,555
- Total income / additions
- $2,070,125,907
- Benefits paid
- $989,259,937
- Administrative expenses
- $0
- Total expenses
- $989,447,907
- Net increase / (decrease)
- $1,080,678,000
- Schedule source
- Schedule H